Publicacions - Fundació Institut d'Investigació en Ciències de la
Publicacions - Fundació Institut d'Investigació en Ciències de la
Publicacions - Fundació Institut d'Investigació en Ciències de la
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Munoz-Mor<strong>en</strong>o, JA; Fumaz, CR; Prats, A; Ferrer, MJ; Negredo, E; Perez-Alvarez, N; Molto, J; Gomez, G;<br />
Garolera, M; Clotet, B<br />
Interruptions of antiretroviral therapy in human immuno<strong>de</strong>fici<strong>en</strong>cy virus infection: are they <strong>de</strong>trim<strong>en</strong>tal<br />
to neurocognitive functioning?<br />
J NEUROVIROL 2010; JUN, 16 (3) 208-218<br />
IF: 2,243<br />
Papagno, L., Alter, G., Assoumou, L., Murphy, R.L., Garcia, F., Clotet, B., Lars<strong>en</strong>, M., Braibant, M.,<br />
Marcelin, A.G., Costaglio<strong>la</strong>, D., Altfeld, M., Kat<strong>la</strong>ma, C., Autran, B., the ORVACS Study Group. 2011.<br />
Compreh<strong>en</strong>sive analysis of virus-specific T-cells provi<strong>de</strong>s clues for the failure of therapeutic<br />
immunization with ALVAC-HIV vaccine<br />
INFECT DIS CLIN N AM 2010;2;25(1):27-36<br />
IF: 3<br />
Pare<strong>de</strong>s R, Ch<strong>en</strong>g I, Kuritzkes DR, Tuoma<strong>la</strong> RE; Wom<strong>en</strong> and Infants Transmission Study (WITS) Group.<br />
Postpartum antiretroviral drug resistance in HIV-1-infected wom<strong>en</strong> receiving pregnancy-limited<br />
antiretroviral therapy.<br />
AIDS 2010 Jan 2;24(1):45-53.<br />
IF: 6,348<br />
Pare<strong>de</strong>s R, Clotet B.Clinical managem<strong>en</strong>t of HIV-1 resistance.<br />
ANTIVIR RES 2010 Jan;85(1):245-65. Epub 2009 Oct 4. Review.<br />
IF: 4,439<br />
Pare<strong>de</strong>s R, La<strong>la</strong>ma CM, Ribaudo HJ, Schackman BR, Shikuma C, Giguel F, Meyer WA 3rd, Johnson VA,<br />
Fiscus SA, D'Aqui<strong>la</strong> RT, Gulick RM, Kuritzkes DR; AIDS Clinical Trials Group (ACTG) A5095 Study Team.<br />
Pre-existing minority drug-resistant HIV-1 variants, adher<strong>en</strong>ce, and risk of antiretroviral treatm<strong>en</strong>t<br />
failure.<br />
J INFECT DIS 2010 Mar;201(5):662-71<br />
IF: 6,288<br />
Patricia E, Domingo P, Gutierrez M, Gracia M, Fuster M, Molto J, Puig J, Perez-Alvarez N, Clotet B,<br />
Negredo E.<br />
Saquinavir/Ritonavir Monotherapy as a New Nucleosi<strong>de</strong>-Sparing Maint<strong>en</strong>ance Strategy in Long-Term<br />
Virologically Suppressed HIV-Infected Pati<strong>en</strong>ts.<br />
CURR HIV RES 2010 Sep 1;8(6):467-70<br />
IF: 1,923<br />
Permanyer M, Bal<strong>la</strong>na E, Esté JA.<br />
Endocytosis of HIV: anything goes.<br />
TRENDS MICROBIOL 2010 Dec;18(12):543-51<br />
IF: 7,5<br />
Pettersson S, Pérez-Nu<strong>en</strong>o VI, M<strong>en</strong>a MP, Clotet B, Esté JA, Borrell JI, Teixidó J.<br />
Novel Monocyc<strong>la</strong>m Derivatives as HIV Entry Inhibitors: Design, Synthesis, Anti-HIV Evaluation, and Their<br />
Interaction with the CXCR4 Co-receptor.<br />
CHEMMEDCHEM 2010 Aug 2;5(8):1272-81<br />
IF: 3,306<br />
Pineda, JA; Gonzalez, J; Ortega, E; Tural, C; Macias, J; Griffa, L; Burgos, A<br />
Pàgina 55 <strong>de</strong> 148